Elucid today announced that, effective January 1, 2026, its Plaque-IQ(TM) coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT(R)) designation, alongside ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Artificial intelligence could soon help expand access to heart disease screening at scale, NewYork-Presbyterian researchers have shown in a new study. Their findings are focused on a deep learning ...

A new machine learning model developed by The George Institute for Global Health can successfully predict heart disease risk in women by analyzing mammograms. The findings were published today in ...

New research can transform how hospitals triage, risk-stratify, and counsel patients to save lives. Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) ...

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced new study data demonstrating that there ...

Researchers from New York City-based Mount Sinai have developed an AI algorithm to help physicians identify patients with hypertrophic cardiomyopathy by assigning a numeric probability risk assessment ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify ...